Die ESHRE-Endometrioseleitlinien: Neuigkeiten und Bestehendes

Arrigo Fruscalzo, Anis Féki, Dorothea Wunder
In: Journal für Gynäkologische Endokrinologie/Schweiz · 2022 · vol. 25(3) , pp. 150–154 · doi:10.1007/s41975-022-00259-7 · W4295678877
article OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-08 ⓘ

This paper reviews the ESHRE guidelines for endometriosis, highlighting updates and existing recommendations for diagnosis and management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text ⓘ

This article discusses updates and existing content from ESHRE endometriosis guidelines by referencing multiple prior guideline documents and related diagnostic studies, with a high-level focus on diagnosis and management approaches and the evidentiary background supporting them. It draws together literature on topics such as diagnostic delays, classification frameworks (including revised #Enzian concepts), and the diagnostic accuracy of various modalities (physical exam, transvaginal sonography, MRI, CA-125, and laparoscopy), but it does not present new primary data. A key limitation is that it is a narrative/guideline overview anchored in previously published sources rather than an original systematic analysis, and it does not itself quantify effect sizes across endpoints. Relevance to endometriosis: the paper is explicitly about ESHRE endometriosis guideline news and existing recommendations, synthesizing evidence directly tied to endometriosis diagnosis and management, though it is not specifically focused on adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 3,472 characters · extracted from oa-doi-fallback · click to expand
Literatur Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L et al (2022) ESHRE guideline: endometriosis. Hum Reprod Open 2022(2):hoac009. https://doi.org/10.1093/hropen/hoac009 Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B et al (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29(3):400–412 Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R et al (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20(10):2698–2704 Evers HJLH (2013) Is adolescent endometriosis a progressive disease that needs to be diagnosed and treated? Hum Reprod 28(8):2023 Ghai V, Jan H, Shakir F, Haines P, Kent A (2020) Diagnostic delay for superficial and deep endometriosis in the United Kingdom. J Obstet Gynaecol 40(1):83–89 Fruscalzo A, Stochino E, Pluchino N, Bouquet de Jolinière J, Feki A (2021) La nouvelle classification de l’endométriose révisée selon #Enzian : finalement une nomenclature complète et efficace ? J Gynäkol Endokrinol. https://doi.org/10.1007/s41975-021-00194-z Bazot M, Lafont C, Rouzier R, Roseau G, Thomassin-Naggara I, Daraï E (2009) Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril 92(6):1825–1833 Hudelist G, Ballard K, English J, Wright J, Banerjee S, Mastoroudes H et al (2011) Transvaginal sonography vs. clinical examination in the preoperative diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol 37(4):480–487 Chen FP, Soong YK, Lee N, Lo SK (1998) The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand 77(6):665–670 Nisenblat V, Bossuyt PMM, Farquhar C, Johnson N, Hull ML (2016) Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2:CD9591 Wykes CB, Clark TJ, Khan KS (2004) Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG 111(11):1204–1212 Kuznetsov L, Dworzynski K, Davies M, Overton C, Guideline Committee (2017) Diagnosis and management of endometriosis: summary of NICE guidance. BMJ 358:j3935 Guo SW (2009) Recurrence of endometriosis and its control. Hum Reprod Update 15(4):441–461 Ballard K, Lowton K, Wright J (2006) What’s the delay? A qualitative study of women’s experiences of reaching a diagnosis of endometriosis. Fertil Steril 86(5):1296–1301 Author information Authors and Affiliations Corresponding author Ethics declarations Interessenkonflikt A. Fruscalzo, A. Feki und D. Wunder geben an, dass kein Interessenkonflikt besteht. Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. Additional information Hinweis des Verlags Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral. Rights and permissions About this article Cite this article Fruscalzo, A., Feki, A. & Wunder, D. Die ESHRE-Endometrioseleitlinien: Neuigkeiten und Bestehendes. J. Gynäkol. Endokrinol. CH 25, 150–154 (2022). https://doi.org/10.1007/s41975-022-00259-7 Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s41975-022-00259-7

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

die_deep_infiltrating

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK